MODERNA INC. DL-,0001 WKN: A2N9D9 ISIN: US60770K1079 Forum: Aktien Thema: Hauptdiskussion

Was für eine Rakete 🚀.. ich nein bei 140 Prozent raus .. Respekt für die die hier sind

Die Iren freuen sich bestimmt 😊😊😊

☺️

Ikke

Freut sich hier keiner? 💃🏼

200 Dollar geknackt ☄️

Was genau willst du mir sagen?

Gilt @Irenfan die Antwort

Welche Iren?

Im Irenforum sind nur noch Dummbacken.warum bist du hier gelandet

Sagt wer?

Kursziel 120$

Hast recht

Moderna (MRNA) Stock Rating Downgraded Amid Valuation Concerns GuruFocus News 10/27/2026 15:10 Article's Main Image On October 27, 2026, investment bank William Blair downgraded Moderna's stock rating from "Outperform" to "Market Perform," citing that the recent surge in stock price has adequately reflected the commercialization prospects of its personalized cancer vaccine. Following the announcement, Moderna's pre-market shares fell approximately 3%. This year, the stock has skyrocketed by about 545%, with a nearly 250% increase since August, largely driven by positive Phase III clinical trial data for its personalized cancer vaccine developed in collaboration with Merck. What's Behind the News? The downgrade from William Blair reflects a cautious stance on Moderna's stock after a remarkable price surge driven by optimism surrounding its personalized cancer vaccine. Analyst Myles Minter highlighted that while the vaccine shows significant potential in treating melanoma, the current stock valuation implies a high success probability for expanding indications, which introduces considerable research risks. The upcoming Phase II trial for kidney cancer will be a critical catalyst, with results expected by late 2026 or 2027.

Das kommt ganz auf die Sichtweisse an .🍀😊